Literature DB >> 1986504

Characterization of spontaneous termination of sustained ventricular tachycardia associated with coronary artery disease.

D J Callans1, F E Marchlinski.   

Abstract

To characterize the change in cycle length and QRS morphology before spontaneous termination of sustained ventricular tachycardia (VT), electrocardiograms were recorded and VT cycle length measured for the periods 31 to 21 and 11 to 1 beats before termination in 55 episodes from 28 patients with coronary artery disease. Beats 31 to 21 were designated as a period of stable arrhythmia and served as a reference for changes occurring just before termination. Forty-four episodes of VT occurred in the setting of antiarrhythmic drug therapy; 11 episodes occurred in patients not treated with antiarrhythmic drugs. Variability in cycle length was indexed by the standard deviation of the mean cycle length and by the percentage of consecutive cycles varying by greater than or equal to 40 ms (% greater than or equal to 40 ms). There was greater variability just before termination (standard deviation of the mean cycle length, 25.8 ms; % greater than or equal to 40 ms, 16.7%) than during the stable period (standard deviation of the mean cycle length, 8.5 ms; % greater than or equal to 40 ms, 5.4%; p less than 0.001 for both). This was true irrespective of antiarrhythmic drug use, although the differences in the standard deviation of the mean cycle length for beats 11 to 1 and for beats 31 to 21 were greater for the antiarrhythmic drug group (29.6 vs 8.9 ms, p less than 0.001) than for the group not receiving antiarrhythmic drugs (11.0 vs 6.7 ms, difference not significant). No specific patterns of cycle length variability characteristic of VT termination were found.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986504     DOI: 10.1016/0002-9149(91)90098-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Effectiveness of first versus successive antitachycardia pacing attempts: predictors and clinical consequences.

Authors:  Javier Jiménez-Candil; Olga Durán; Jean Núñez; Loreto Bravo; Jesús Hernández; Ana Martín-García; José Morínigo; Pedro L Sánchez
Journal:  J Interv Card Electrophysiol       Date:  2019-09-16       Impact factor: 1.900

2.  What factors lead to the acceleration of ventricular tachycardia during antitachycardia pacing?-Results from over 1000 episodes.

Authors:  Yin Fang; Kai Gu; Bing Yang; Weizhu Ju; Hongwu Chen; Mingfang Li; Hailei Liu; Jiaxian Wang; Gang Yang; Minglong Chen
Journal:  J Arrhythm       Date:  2017-12-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.